Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Structure (London, England : 1993)
|
December 14, 2011
Face-to-face, pak-to-pak
Kimberly A Malecka, Jeffrey R Peterson
The Journal of Biological Chemistry
|
February 9, 2013
Synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases
Kimberly A Malecka, Zsofia Szentpetery, Jeffrey R Peterson
Journal of Virology
|
July 14, 2017
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance
Julianna S Deakyne, Kimberly A Malecka, Troy E Messick, et al.
Journal of Virology
|
May 31, 2019
Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication
Kimberly A Malecka, Jayaraju Dheekollu, Julianna S Deakyne, et al.
ACS Chemical Biology
|
May 24, 2014
Identification and characterization of small molecule human papillomavirus E6 inhibitors
Kimberly A Malecka, Daniela Fera, David C Schultz, et al.
Molecular Therapy. Methods & Clinical Development
|
September 29, 2025
pH-dependent DNA degradation pathways for adeno-associated virus gene therapy
Jefferson S Plegaria, Kimberly A Malecka, Qi Lin, et al.
Journal of Pharmaceutical Sciences
|
June 14, 2025
Particle size distribution resolution limit of AAV hs-SV-AUC relative to ls-SV-AUC, mass photometry, and charge-detection mass spectrometry
Bashkim Kokona, Austin Vogt, Neal Whitaker, et al.
Science Translational Medicine
|
March 8, 2019
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Troy E Messick, Garry R Smith, Samantha S Soldan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Structure (London, England : 1993)
|
December 14, 2011
Face-to-face, pak-to-pak
Kimberly A Malecka, Jeffrey R Peterson
The Journal of Biological Chemistry
|
February 9, 2013
Synergistic activation of p21-activated kinase 1 by phosphatidylinositol 4,5-bisphosphate and Rho GTPases
Kimberly A Malecka, Zsofia Szentpetery, Jeffrey R Peterson
Journal of Virology
|
July 14, 2017
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance
Julianna S Deakyne, Kimberly A Malecka, Troy E Messick, et al.
Journal of Virology
|
May 31, 2019
Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication
Kimberly A Malecka, Jayaraju Dheekollu, Julianna S Deakyne, et al.
ACS Chemical Biology
|
May 24, 2014
Identification and characterization of small molecule human papillomavirus E6 inhibitors
Kimberly A Malecka, Daniela Fera, David C Schultz, et al.
Molecular Therapy. Methods & Clinical Development
|
September 29, 2025
pH-dependent DNA degradation pathways for adeno-associated virus gene therapy
Jefferson S Plegaria, Kimberly A Malecka, Qi Lin, et al.
Journal of Pharmaceutical Sciences
|
June 14, 2025
Particle size distribution resolution limit of AAV hs-SV-AUC relative to ls-SV-AUC, mass photometry, and charge-detection mass spectrometry
Bashkim Kokona, Austin Vogt, Neal Whitaker, et al.
Science Translational Medicine
|
March 8, 2019
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Troy E Messick, Garry R Smith, Samantha S Soldan, et al.
Page
of 1